155 related articles for article (PubMed ID: 14522122)
1. Improvement in the bioavailability of poorly absorbed glycyrrhizin via various non-vascular administration routes in rats.
Sasaki K; Yonebayashi S; Yoshida M; Shimizu K; Aotsuka T; Takayama K
Int J Pharm; 2003 Oct; 265(1-2):95-102. PubMed ID: 14522122
[TBL] [Abstract][Full Text] [Related]
2. Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles.
Jin S; Fu S; Han J; Jin S; Lv Q; Lu Y; Qi J; Wu W; Yuan H
J Drug Target; 2012 Aug; 20(7):615-22. PubMed ID: 22726209
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics and pharmacokinetics of recombinant hirudin via four non-parenteral routes.
Liu Y; Lu WL; Zhang X; Wang XQ; Zhang H; Zhang Q
Peptides; 2005 Mar; 26(3):423-30. PubMed ID: 15652649
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis.
Takeda S; Ishthara K; Wakui Y; Amagaya S; Maruno M; Akao T; Kobashi K
J Pharm Pharmacol; 1996 Sep; 48(9):902-5. PubMed ID: 8910850
[TBL] [Abstract][Full Text] [Related]
5. Repetitive administration of Shaoyao-Gancao-tang to rats restores the bioavailability of glycyrrhizin reduced by antibiotic treatment.
He JX; Akao T; Tani T
J Pharm Pharmacol; 2003 Nov; 55(11):1569-75. PubMed ID: 14713369
[TBL] [Abstract][Full Text] [Related]
6. Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability.
Yamamura Y; Santa T; Kotaki H; Uchino K; Sawada Y; Iga T
Biol Pharm Bull; 1995 Feb; 18(2):337-41. PubMed ID: 7742809
[TBL] [Abstract][Full Text] [Related]
7. The effect of fatty acids on the rectal absorption of acyclovir in rats.
Yamazaki M; Itoh S; Sawanoi M; Kobayashi M; Suzuki S; Komatsu T; Tanabe K
J Pharm Pharmacol; 1990 Jun; 42(6):441-3. PubMed ID: 1979629
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of ketotifen fumarate after intravenous, intranasal, oral and rectal administration in rabbits.
Yagi N; Taniuchi Y; Hamada K; Sudo J; Sekikawa H
Biol Pharm Bull; 2002 Dec; 25(12):1614-8. PubMed ID: 12499650
[TBL] [Abstract][Full Text] [Related]
9. A highly sensitive LC-MS/MS method for simultaneous determination of glycyrrhizin and its active metabolite glycyrrhetinic acid: Application to a human pharmacokinetic study after oral administration.
Suzuki T; Tsukahara M; Akasaka Y; Inoue H
Biomed Chromatogr; 2017 Dec; 31(12):. PubMed ID: 28623864
[TBL] [Abstract][Full Text] [Related]
10. Intestinal absorption and biliary elimination of glycyrrhizic acid diethyl ester in rats.
Koga K; Kawamura M; Iwase H; Yoshikawa N
Drug Des Devel Ther; 2013; 7():1235-43. PubMed ID: 24174868
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhizin accelerates the metabolism of triptolide through induction of CYP3A in rats.
Tai T; Huang X; Su Y; Ji J; Su Y; Jiang Z; Zhang L
J Ethnopharmacol; 2014 Mar; 152(2):358-63. PubMed ID: 24486211
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats.
Pelser A; Müller DG; du Plessis J; du Preez JL; Goosen C
Biopharm Drug Dispos; 2002 Sep; 23(6):239-44. PubMed ID: 12214324
[TBL] [Abstract][Full Text] [Related]
13. [Novel formulations of a liver protection drug glycyrrhizin].
Koga K; Kawashima S; Shibata N; Takada K
Yakugaku Zasshi; 2007 Jul; 127(7):1103-14. PubMed ID: 17603270
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury.
Makino T; Ohtake N; Watanabe A; Tsuchiya N; Imamura S; Iizuka S; Inoue M; Mizukami H
Drug Metab Dispos; 2008 Jul; 36(7):1438-43. PubMed ID: 18362159
[TBL] [Abstract][Full Text] [Related]
15. [The absorption features of glycyrrhizic acid in composition of drug "phosphogliv"].
Voskresenskaia AA; Medvedeva NV; Prozorovskiĭ VN; Moskaleva NE; Ipatova OM
Biomed Khim; 2012; 58(5):564-72. PubMed ID: 23289298
[TBL] [Abstract][Full Text] [Related]
16. Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.
Higaki K; Yata T; Sone M; Ogawara K; Kimura T
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):231-40. PubMed ID: 11758652
[TBL] [Abstract][Full Text] [Related]
17. [Determination of glycyrrihizin in rats plasma and pharmacokinetics after oral administration of si-jun-zi-tang].
Zhang L; Huang X; Wang L; Reng P; Feng J; Chen J
Zhong Yao Cai; 2000 Sep; 23(9):563-5. PubMed ID: 12575285
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic comparison of prostaglandin E1 administered by different routes to rats.
Gu FG; Cui FD; Gao YL
Yao Xue Xue Bao; 2007 Jul; 42(7):787-93. PubMed ID: 17882966
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of glycyrrhizin from Shaoyao-Gancao-Tang in laxative-treated rats.
Goto E; He JX; Akao T; Tani T
J Pharm Pharmacol; 2005 Oct; 57(10):1359-63. PubMed ID: 16259766
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic study of neostigmine after intranasal and intravenous administration in the guinea pig.
Fossati A; Vimercati MG; Bandi GL; Formenti A
Drugs Exp Clin Res; 1990; 16(11):575-9. PubMed ID: 2101780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
